X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Guest Post: The Clinical trial experience from a patient & researcher perspective

By Guest Contributor  |    May 5, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Guest Post: Patients as research partners - Rethinking patient access to clinical trial data

By Guest Contributor  |    May 4, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Guest Post: Spotlighting the heroes in clinical trials

By Guest Contributor  |    May 3, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Guest Post: Advancing oncology research through clinical trials

By Guest Contributor  |    May 2, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Clinical Trials Awareness Week: Celebrating the impact of clinical research

By Andrew Powaleny  |    May 1, 2017
Today starts off the beginning of Clinical Trials Awareness Week, which shines a spotlight on how the clinical trials process helps deliver safe, effective medicines to patients.   Read More

Watch: Biomarkers in drug development with Dr. Bernie Zeiher

By Andrew Powaleny  |    February 14, 2017
Biomarkers are powerful tools which are used by medical professionals in many ways, including in the diagnosis of disease, monitoring how a disease is progressing and, if a treatment is given, how...   Read More

The Science of Hope: Understanding biomarkers

By Andrew Powaleny  |    May 18, 2016
In the age of personalized medicine, biomarkers (short for “biological markers”) are emerging as important tools in drug development. A biomarker is a measure or physical sign that can be used to...   Read More

Lessons learned: Clinical trials

By Andrew Powaleny  |    May 9, 2016
A dynamic and collaborative health care ecosystem is crucial to conducting efficient and effective clinical trials, but two-thirds of trials fail to enroll enough participants. Misconceptions and...   Read More

Clinical Trials Q&A: A patient’s perspective

By Jocelyn Ulrich  |    May 4, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Coming soon: Clinical Trials Awareness Week, May 2-6

By Andrew Powaleny  |    April 28, 2016
Clinical trials are the most effective way to find new, innovative treatments for illnesses patients may face. But misconceptions and lack of awareness about this important research often keep...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates